网页Octreoscan™ (Kit for the Preparation of Indium In 111 Pentetreotide Injection) Diagnostic For Intravenous Use. Rx only DESCRIPTION Octreoscan™ is a kit for the preparation
Contact网页Octreoscan™ Kit for the Preparation of Indium In 111 Pentetreotide Diagnostic For Intravenous Use. Rx only DESCRIPTION Octreoscan is a kit for the preparation of
Contact网页Octreoscan ™ is a kit for the preparation of Indium In 111 Pentetreotide Injection, a radioactive diagnostic agent. It is a kit consisting of two components: 1) A 10-mL
Contact网页Octreoscan™ Kit for the Preparation of Indium In 111 Pentetreotide 050 ADVERSE REACTIONS The following adverse effects were observed in clinical trials at a frequency
Contact网页2022年2月21日OCTREOSCAN- indium in -111 pentetreotide Curium US LLC DESCRIPTION Octreoscan ™ is a kit for the preparation of Indium In 111
Contact网页Octreoscan™ is a kit for the preparation of indium In-111 pentetreotide, a diagnostic radio phar maceutical. It is a kit con-sisting of two components: 1) A 10-mL Octreoscan
Contact网页Patient Preparation When appropriate, consideration should begiven to discontinuing octreotide therapy for 24 hr prior to In-111 pentetreotide administra-tion, with monitoring
Contact网页The kit consists of two vials: Vial A: Radiopharmaceutical precursor. Clear and colourless solution. Vial B: Powder for solution for injection. White lyophylised powder. Qualitative
Contact网页4.7. Effects on ability to drive and use machines. Octreoscan has no or negligible influence on the ability to drive and use machines. 4.8. Undesirable effects. Adverse effects
Contact网页2022年2月21日The Octreoscan kit should be stored refrigerated at 2° to 8°C (36° to 46°F). After reconstitution, store at controlled room temperature 20° to 25°C (68° to 77°F). Indium In 111 Pentetreotide Injection must be used within 6 hours of preparation. INSTRUCTIONS FOR THE PREPARATION OF INDIUM In 111 PENTETREOTIDE
Contact网页OctreoScan is ordered as a package containing both the cold Octreotide and a vial of In-111 Chloride. The dose may also be ordered in unit dose form from the local radiopharmacy. As such, standard adult dose is up to 6 mCi + 20% (4.8-7.2 mCi). Doses will be adjusted for patients per the nomogram/NMIS.
Contact网页OctreoScan® Kit for the Preparation of Indium In-111 Pentetreotide Diagnostic For Intravenous Use. Rx Only. DESCRIPTION OctreoScan® is a kit for the preparation of Indium In-111 pentetreotide, a diagnostic radiopharmaceutical. It is a kit consisting of two components: 1) A 10-mL OctreoScan® Reaction Vial which contains a lyophilized
Contact网页Patient Preparation When appropriate, consideration should begiven to discontinuing octreotide therapy for 24 hr prior to In-111 pentetreotide administra-tion, with monitoring the patient for signs ofwithdrawal. See also Section K.2.a.
Contact网页Radiopharmaceutical: In-111 OctreoScan (pentetreotide) Dose (Adult/Pediatric): Refer to Nuclear Medicine Dose Chart . Route of Administration: Intravenous . Patient Preparation: Please ensure the following: • Tumor uptake of the radiopharmaceutical may be reduced (although usually not completely eliminated) in patients being treated with
Contact网页Octreoscan is supplied as one pack containing two vials: Vial A: a 10 ml quartz-coated, type I glass vial with a teflon-coated bromobutyl rubber stopper and shielded with lead containing 1.1. ml of indium(111 In)chloride solution corresponding to 122 MBq at activity reference time. Vial B: 10 mL type I glass vial closed with a bromobutyl rubber stopper and orange
Contact网页First the technologist will scan your body from head to knees. This scan takes about 20 minutes. These images will be shown to the radiologist and the radiologist will determine if another set of images is needed on this day. If needed, the technologist will take another set of images called a SPECT/CT. This is a tomographic set of images
Contact网页Octreoscan is a kit for the preparation of indium In-111 pentetreotide, a diagnostic radiopharmaceutical. It is a kit consisting of two components: 1) A 10-mL Octreoscan Reaction Vial which contains a lyophilized mixture of:
Contact网页4.7. Effects on ability to drive and use machines. Octreoscan has no or negligible influence on the ability to drive and use machines. 4.8. Undesirable effects. Adverse effects attributable to the administration of Octreoscan are uncommon (1/1000 to <1/100). Specific effects have not been observed. The symptoms reported are suggestive of
Contact网页商品名:octreoscan,活性成分:indium in-111 pentetreotide kit,申请号:020314,申请人:curium. 药品注册申请号:020314. 申请类型:nda (新药申请) 申请人:curium. 申请人全名:curium us llc.
Contact网页Octreoscan ™ is a kit for the preparation of indium In-111 pentetreotide, a diagnostic radiopharmaceutical. It is a kit consisting of two components: 1) A 10-mL Octreoscan Reaction Vial which contains a lyophilized mixture of:
Contact网页Octreoscan Kit for preparation of 111In-Pentetreotide 111 MBq/ ml QUALITATIVE AND QUANTITATIVE COMPOSITION Octreoscan is supplied as two vials which cannot be used separately.
Contact网页Trade Name Octreoscan 111 MBq/mL, kit for radiopharmaceutical preparation. Active Substances Indium (111 in) chloride solution Pentetreotide. Dosage Form Kit for radiopharmaceutical preparation. Licence Holder Curium Netherlands B.V. Licence Number PA0690/001/001. Group Information. ATC Code V09AX01 indium (111In) pentetic acid.
Contact网页Octreoscan™ (kit for the preparation of indium In 111 pentetreotide) is used to detect and localize primary and metastatic neuroendocrine tumors that have somatostatin receptors. The neuroendocrine system is made up of the nervous system and the hormones and the glands that make and release them into the bloodstream. Neuroendocrine
Contact网页Radiopharmaceutical: In-111 OctreoScan (pentetreotide) Dose (Adult/Pediatric): Refer to Nuclear Medicine Dose Chart . Route of Administration: Intravenous . Patient Preparation: Please ensure the following: • Tumor uptake of the radiopharmaceutical may be reduced (although usually not completely eliminated) in patients being treated with
Contact网页Trade Name Octreoscan 111 MBq/mL, kit for radiopharmaceutical preparation. Active Substances Indium (111 in) chloride solution Pentetreotide. Dosage Form Kit for radiopharmaceutical preparation. Licence Holder Curium Netherlands B.V. Licence Number PA0690/001/001. Group Information. ATC Code V09AX01 indium (111In) pentetic acid.
Contact网页Octreoscan is supplied as one pack containing two vials: Vial A: a 10 ml quartz-coated, type I glass vial with a teflon-coated bromobutyl rubber stopper and shielded with lead containing 1.1. ml of indium(111 In)chloride solution corresponding to 122 MBq at activity reference time. Vial B: 10 mL type I glass vial closed with a bromobutyl rubber stopper and orange
Contact网页Octreoscan Kit for preparation of 111In-Pentetreotide 111 MBq/ ml QUALITATIVE AND QUANTITATIVE COMPOSITION Octreoscan is supplied as two vials which cannot be used separately.
Contact网页How should I prepare for an Octreotide scan? There is no special prep for this exam. How long does the test take? There are typically 3 visits to the Nuclear Medicine Department in order to complete this test. On you first visit a small injection of a radioactive isotope will be injected into a vein. There are no side effects to this injection.
Contact网页OCTREOSCAN Kit for radiopharmaceutical preparation Active ingredients: Overview Usage Precautions Pharmacology 4.3. Contraindications Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4. Special warnings and precautions for use Potential for hypersensitivity or anaphylactic reactions
Contact网页Octreoscan ™ is a kit for the preparation of indium In-111 pentetreotide, a diagnostic radiopharmaceutical. It is a kit consisting of two components: 1) A 10-mL Octreoscan Reaction Vial which contains a lyophilized mixture of:
Contact网页Exam Preparation: Somatostatin therapy must be discontinued prior to this exam, usually 3 days. Contact the nuclear medicine department to verify. Other nuclear exams performed within 2-3 days may interfere. Imaging studies using oral barium performed within 2-3 days may interfere. Preparation for imaging days after the initial appointment is
Contact网页商品名:octreoscan,活性成分:indium in-111 pentetreotide kit,申请号:020314,申请人:curium. 药品注册申请号:020314. 申请类型:nda (新药申请) 申请人:curium. 申请人全名:curium us llc.
Contact网页Our extensive portfolio of products includes generators, cold kits, hot products and auxiliary products used in the diagnosis and treatment of a wide range of diseases affecting the thyroid, lungs, liver, bones, brain, heart, glands, kidneys and joints. European products. North American
Contact网页2022年11月29日Use OctreoScan (indium in-111 pentetreotide) as ordered by your doctor. Read all information given to you. Follow all instructions closely. It is given as a shot into a vein. Your doctor may tell you to use a laxative like bisacodyl or lactulose before and after getting OctreoScan (indium in-111 pentetreotide).
Contact网页Octreoscan Prices, Coupons and Patient Assistance Programs. Octreoscan (indium pentetreotide in-111) is a member of the diagnostic radiopharmaceuticals drug class. The cost for Octreoscan intravenous kit (3 mCi/mL) is around $2,617 for a supply of 1 kits, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and
Contact网页Proper name: Kit for the preparation of Indium In 111 Pentetreotide . Pharmacology classification: Radiodiagnostic agent. Distributed by: Curium Canada Inc. The Octreoscan™ is a kit for the preparation of Indium In 111 Pentetreotide, a diagnostic radiopharmaceutical. It is a kit consisting of two components:
Contact